Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Furnari

Showing results (91-100 of 115) with videos related to

Pageof 12
Sort By:
Biorxiv : the Preprint Server for Biology|March 3, 2023
Cooperativity between H3.3K27M and PDGFRA poses multiple therapeutic vulnerabilities in human iPSC-derived diffuse midline glioma avatarsKasey R Skinner, Tomoyuki Koga, Shunichiro Miki, et al.
Cell Metabolism|July 16, 2019
Oncogene Amplification in Growth Factor Signaling Pathways Renders Cancers Dependent on Membrane Lipid RemodelingJunfeng Bi, Taka-Aki Ichu, Ciro Zanca, et al.
Nature Communications|January 30, 2020
Longitudinal assessment of tumor development using cancer avatars derived from genetically engineered pluripotent stem cellsTomoyuki Koga, Isaac A Chaim, Jorge A Benitez, et al.
Nature Communications|April 22, 2020
Author Correction: Longitudinal assessment of tumor development using cancer avatars derived from genetically engineered pluripotent stem cellsTomoyuki Koga, Isaac A Chaim, Jorge A Benitez, et al.
Neuro-Oncology Advances|September 14, 2023
Combined inhibition of topoisomerase I and poly(ADP-ribose) polymerase: A synergistic therapeutic strategy for glioblastoma with phosphatase and tensin homolog deficiencyOlga Kim, Madison Butler, Zach Sergi, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2012
Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240Tim R Fenton, David Nathanson, Claudio Ponte de Albuquerque, et al.
Cancer Cell|March 5, 2019
Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA RepairJianhui Ma, Jorge A Benitez, Jie Li, et al.
Molecular Cell|October 13, 2015
EGFR Mutation Promotes Glioblastoma through Epigenome and Transcription Factor Network RemodelingFeng Liu, Gary C Hon, Genaro R Villa, et al.
Cell Reports|November 3, 2021
Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drugJunfeng Bi, Atif Khan, Jun Tang, et al.
Science (New York, N.Y.)|December 7, 2013
Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNADavid A Nathanson, Beatrice Gini, Jack Mottahedeh, et al.
Pageof 12

Showing results (91-100 of 115) with videos related to

Sort By:
Pageof 12
Biorxiv : the Preprint Server for Biology|March 3, 2023
Cooperativity between H3.3K27M and PDGFRA poses multiple therapeutic vulnerabilities in human iPSC-derived diffuse midline glioma avatarsKasey R Skinner, Tomoyuki Koga, Shunichiro Miki, et al.
Cell Metabolism|July 16, 2019
Oncogene Amplification in Growth Factor Signaling Pathways Renders Cancers Dependent on Membrane Lipid RemodelingJunfeng Bi, Taka-Aki Ichu, Ciro Zanca, et al.
Nature Communications|January 30, 2020
Longitudinal assessment of tumor development using cancer avatars derived from genetically engineered pluripotent stem cellsTomoyuki Koga, Isaac A Chaim, Jorge A Benitez, et al.
Nature Communications|April 22, 2020
Author Correction: Longitudinal assessment of tumor development using cancer avatars derived from genetically engineered pluripotent stem cellsTomoyuki Koga, Isaac A Chaim, Jorge A Benitez, et al.
Neuro-Oncology Advances|September 14, 2023
Combined inhibition of topoisomerase I and poly(ADP-ribose) polymerase: A synergistic therapeutic strategy for glioblastoma with phosphatase and tensin homolog deficiencyOlga Kim, Madison Butler, Zach Sergi, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2012
Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240Tim R Fenton, David Nathanson, Claudio Ponte de Albuquerque, et al.
Cancer Cell|March 5, 2019
Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA RepairJianhui Ma, Jorge A Benitez, Jie Li, et al.
Molecular Cell|October 13, 2015
EGFR Mutation Promotes Glioblastoma through Epigenome and Transcription Factor Network RemodelingFeng Liu, Gary C Hon, Genaro R Villa, et al.
Cell Reports|November 3, 2021
Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drugJunfeng Bi, Atif Khan, Jun Tang, et al.
Science (New York, N.Y.)|December 7, 2013
Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNADavid A Nathanson, Beatrice Gini, Jack Mottahedeh, et al.
Pageof 12